Targeting the endothelin system: a step towards a precision medicine approach in heart failure with preserved ejection fraction?

No abstract is available for this paper.

• Publication year

  2019

• Venue

  European Heart Journal

• Publication date

  2019-11-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehz765PMID 31682255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction

  2019cited by this paper
• The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

  2019cited by this paper
• Adrenomedullin in heart failure: pathophysiology and therapeutic application

  2018cited by this paper
• Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.

  2018cited by this paper
• Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction

  2018cited by this paper
• Heart failure with preserved ejection fraction: from mechanisms to therapies

  2018cited by this paper
• Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction

  2017cited by this paper
• Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial).

  2017cited by this paper
• Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training

  2017cited by this paper
• Endothelin

  2016cited by this paper
• Association of Elevated Plasma Endothelin-1 Levels With Pulmonary Hypertension, Mortality, and Heart Failure in African American Individuals: The Jackson Heart Study.

  2016cited by this paper
• 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

  2016cited by this paper
• Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction

  2016cited by this paper
• Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction.

  2014cited by this paper
• Plasma Endothelin Determination as a Prognostic Indicator of 1-Year Mortalit After Acute Myocardial Infarction

  2005cited by this paper
• Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction.

  1994cited by this paper
• Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

  1993cited by this paper
• Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure

  1992cited by this paper

• Efficacy and safety of Salvia miltiorrhiza and ligustrazine injection for heart failure: a systematic review and meta-analysis.

  2026cites this paper
• Difference Analysis of N-Terminal B-Type Natriuretic Peptide, High-Sensitivity Troponin I, and Endothelin-1 Levels in Patients With Normotensive and Hypertensive Acute Heart Failure

  2025cites this paper
• Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure?

  2023cites this paper
• Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF

  2022cites this paper
• The growing role of genetics in the understanding of cardiovascular diseases: towards personalized medicine.

  2021cites this paper
• Endothelin-1 and peak oxygen consumption in patients with heart failure with preserved ejection fraction.

  2021cites this paper
• Focus on hypertension but also on the 'the digital twin' and on kidney function and disease.

  2020cites this paper
• The wide spectrum of ischaemic heart disease: the emerging role of functional coronary alterations and their interaction with coronary stenoses.

  2020cites this paper
• Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

  2020cites this paper
• HFpEF: an enigma being slowly but surely unravelled.

  2019cites this paper